Personal paper - New drug treatment for Alzheimer's disease: lessons for healthcare policy

被引：89
作者：
Melzer, D [1 ]
机构：
[1] Univ Cambridge, Inst Publ Hlth, Dept Community Med, Cambridge CB2 2SR, England
来源：
BMJ-BRITISH MEDICAL JOURNAL | 1998年 / 316卷 / 7133期
关键词：
D O I：
10.1136/bmj.316.7133.762
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：762 / 764
页数：3
相关论文
共 20 条
[1]  
AbelSmith B, 1996, OECD HEAL POL STUD, P17
[2]   Policy issues in the private health sector: Examples from long-term care in the U.K. [J].
Bartlett, HP ;
Phillips, DR .
SOCIAL SCIENCE & MEDICINE, 1996, 43 (05) :731-737
[3]  
EATON L, 1997, HLTH SERV J, V107, P6
[4]  
*EIS CORP, 1996, ARICEPT DONEPEZIL LE
[5]  
FERRIMAN A, 1997, INDEPENDENT 0328, P13
[6]  
FLETCHER D, 1997, DAILY TELEGRAPH 0405, P9
[7]   Advertisements for donepezil (Aricept) in the BMJ - Advertisement suggests an unrealistic improvement in mental status [J].
Gray, S .
BRITISH MEDICAL JOURNAL, 1997, 314 (7093) :1555-1555
[8]  
IMPALLOMINI M, 1994, LANCET, V334, P1230
[9]   Drug treatments for Alzheimer's disease - Raise clinical and ethical problems [J].
Kelly, CA ;
Harvey, RJ ;
Cayton, H .
BRITISH MEDICAL JOURNAL, 1997, 314 (7082) :693-694
[10]  
LAURANCE J, 1997, TIMES 0328, P6
12